Analyst consensus rating
Heron Therapeutics Analyst Rating: none
Direct answer
Heron Therapeutics's consensus rating is none.
3 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $7.00.
Forecast evidence checked September 17, 2026.
Get free Heron Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $0.32
- Average price target
- $7.00
- High price target
- $9.00
- Low price target
- $5.00
- Low target gap
- +1,473.3%
- Target upside
- +2,102.6%
- High target gap
- +2,732%
- Target range width
- 1,258.7%
- Consensus rating
- none
- Analysts
- 3
- Evidence date
- September 17, 2026
- Valid through
- September 24, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Heron Therapeutics?
Heron Therapeutics has a verified none consensus. The same dataset has an average price target of $7.00.
How far are Heron Therapeutics's low and high targets from the recorded price?
The low target implies +1,473.3%, while the high target implies +2,732%.
How many analysts are included in Heron Therapeutics's consensus?
The verified consensus includes 3 analysts.
How is Heron Therapeutics's target upside or downside calculated?
The average target of $7.00 is divided by the recorded price of $0.32, then one is subtracted to produce +2,102.6%. This does not guarantee a future return.
When was Heron Therapeutics's analyst forecast verified?
The data was verified on 2026-09-17. The dataset is valid through 2026-09-24.